CompoAtlas

Lipo-Matrix

Natural health product licensed in Canada

Licence holder
Cyto-Matrix Inc.
NPN or DIN-HM
80057845
Status
Active licence
Licence date
2 February 2015
Revision date
3 March 2026
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Monascus purpurea-fermented Oryza sativa

Source : Oryza sativa

75 milligrammeNot calculated
Monascus purpurea-fermented Oryza sativa

Source : En entier

75 milligrammeNot calculated
Policosanol

Source : Saccharum officinarum - cire

7 milligrammeNot calculated
Commiphora wightii

Source : Fruit Resin

Extraction ratio : 4:1

Dry plant equivalent : 200 milligramme

Potency : 10 Pour cent guggulsterone

50 milligrammeNot calculated
hexanicotinyl cis-1,2,3,5-trans-4,6-cyclohexane400 milligrammeNot calculated
L-Méthylfolate300 microgrammesNot calculated
Vitamine B650 milligramme100,000 µg
Vitamine B12300 microgrammesNot calculated
Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium

Source : Beta vulgaris - Racine

100 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, Silicon dioxide colloïdal, Stéarate de magnésium, Microcrystalline cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to support healthy cholesterol and triglyceride levels. Helps to lower elevated LDL cholesterol. Helps to improve lipid profile and support cardiovascular health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80057845

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line